News|Articles|August 1, 2023
Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia
Author(s)Mikart
Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
Women in STEM: Early Phase Drug Development
4
PharmTech Weekly Roundup - February 6, 2026
5